Larvol Delta - AltruBio-to-Present-New-Phase-1b-Data-Evaluating-Neihulizumab-ALTB168-in-Patients-with-SteroidRefractory-or-TreatmentRefractory-Acute-GraftVersusHostDisease-at-the-64th-ASH-Annual-Meeting-2022

neihulizumab (ALTB-168) - AltruBio

https://www.globenewswire.com/news-release/2022/11/03/2547769/0/en/AltruBio-to-Present-New-Phase-1b-Data-Evaluating-Neihulizumab-ALTB-168-in-Patients-with-Steroid-Refractory-or-Treatment-Refractory-Acute-Graft-Versus-Host-Disease-at-the-64th-ASH-A.html

Nov 3, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next